Gaujoux-Viala C - Search Results

1

[Schwannoma of the duodenojejunal angle].

Gaujoux-Viala C, Cervera P, Lepeule R, Kettaneh A, Toledano C, Svrek M, Cabane J, Tiev KP. Gaujoux-Viala C, et al. Rev Med Interne. 2008 Jan;29(1):68-70. doi: 10.1016/j.revmed.2007.09.033. Epub 2007 Oct 22. Rev Med Interne. 2008. PMID: 18006195 French.

2

Langerhans' cell histiocytosis of the liver in adults.

Abdallah M, Généreau T, Donadieu J, Emile JF, Chazouillères O, Gaujoux-Viala C, Cabane J. Abdallah M, et al. Clin Res Hepatol Gastroenterol. 2011 Jun;35(6-7):475-81. doi: 10.1016/j.clinre.2011.03.012. Epub 2011 May 6. Clin Res Hepatol Gastroenterol. 2011. PMID: 21550330

3

[The main directions in case of polyarthritis].

Gaujoux-Viala C. Gaujoux-Viala C. Rev Prat. 2012 Oct;62(8):1069-76. Rev Prat. 2012. PMID: 23227598 French.

4

Osteomyelitis in adults: an underrecognized clinical entity in immunocompetent hosts. A report of six cases.

Gaujoux-Viala C, Zeller V, Leclerc P, Chicheportiche V, Mamoudy P, Desplaces N, Ziza JM. Gaujoux-Viala C, et al. Joint Bone Spine. 2011 Jan;78(1):75-9. doi: 10.1016/j.jbspin.2010.03.001. Epub 2010 Aug 25. Joint Bone Spine. 2011. PMID: 20800526

5

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

Gaujoux-Viala C, Smolen JS, Landewé R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L. Gaujoux-Viala C, et al. Ann Rheum Dis. 2010 Jun;69(6):1004-9. doi: 10.1136/ard.2009.127225. Epub 2010 May 6. Ann Rheum Dis. 2010. PMID: 20447954 Review.

6

Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B. Gaujoux-Viala C, et al. J Rheumatol. 2011 Aug;38(8):1576-84. doi: 10.3899/jrheum.101006. Epub 2011 May 1. J Rheumatol. 2011. PMID: 21532054

7

Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B. Gaujoux-Viala C, et al. Ann Rheum Dis. 2012 Sep;71(9):1478-83. doi: 10.1136/annrheumdis-2011-200891. Epub 2012 Mar 14. Ann Rheum Dis. 2012. PMID: 22419775

8

Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort.

Gaujoux-Viala C, Paternotte S, Combe B, Dougados M. Gaujoux-Viala C, et al. Rheumatology (Oxford). 2012 Sep;51(9):1648-54. doi: 10.1093/rheumatology/kes135. Epub 2012 Jun 1. Rheumatology (Oxford). 2012. PMID: 22661552

9

Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort.

Gaujoux-Viala C, Fautrel B, Guillemin F, Flipo RM, Bourgeois P, Rat AC. Gaujoux-Viala C, et al. Rheumatology (Oxford). 2013 May;52(5):832-8. doi: 10.1093/rheumatology/kes270. Epub 2012 Oct 22. Rheumatology (Oxford). 2013. PMID: 23093721

10

[Spondyloarthropathies].

Gaujoux-Viala C. Gaujoux-Viala C. Rev Prat. 2012 Oct;62(8):1072. Rev Prat. 2012. PMID: 23227599 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters